WATCH LIVE
timothy sykes logo
PETS Stock Whipsaws As Turnaround Effort Meets Revenue Slide Thumbnail
G Google News

PETS Stock Whipsaws As Turnaround Effort Meets Revenue Slide

TIM SYKES•UPDATED JUN. 29, 2026, 2:32 PM ET
Reviewed by Bryce Tuoheyand Fact-checked by Matt Monaco

PetMed Express Inc. stocks have been trading up by 5.06 percent amid heightened optimism from strong earnings and growth prospects.

Key Takeaways

  • Q4 EPS came in at -$0.19 for PetMed Express, a sharp improvement from -$0.56 a year earlier.
  • Quarterly revenue dropped to $42.82M from $50.76M, keeping pressure on the top line.
  • Management at PETS points to sequential net sales improvement and cost cuts as early turnaround progress.
  • New B2B and white-label efforts, including a Rural King agreement, aim to boost retention and widen the PETS market reach.

Candlestick Chart

Live Update At 14:32:18 EDT: On Monday, June 29, 2026 PetMed Express Inc. stock [NASDAQ: PETS] is trending up by 5.06%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

PETS is trading like a classic turnaround penny play. The stock has been grinding between roughly $1.70 and $2.35 over the recent sessions, with the latest close around $1.85 after a failed push toward the $2.30–$2.35 area. For short-term traders, that 2-handle is acting like a battleground zone.

On the fundamentals, PetMed Express reported Q4 EPS of -$0.19, better than last year’s -$0.56, so losses are shrinking. But revenue fell to $42.82M from $50.76M, and full-year revenue of about $179.0M has been trending down for several years. PETS is still a money loser: profit margins are deeply negative, free cash flow for the quarter was about -$5.46M, and operating cash flow was roughly -$4.74M.

More Breaking News

The balance sheet, however, gives PETS some runway. The company shows $21.4M in cash against very low debt, and an enterprise value near $16.7M suggests the market has heavily discounted the business. With a price-to-sales ratio around 0.27 and price-to-book near 1.66, traders are clearly pricing in serious risk but also leaving room for a turnaround if management delivers.

Why Traders Are Watching PETS Now

PETS has become the kind of chart active traders love to study: beaten down, liquid enough, and moving on real news. The latest earnings report put PetMed Express squarely into “show me” mode. Q4 EPS improved to -$0.19 from -$0.56, which tells you management is finding ways to plug some of the leaks. At the same time, revenue dropped from $50.76M to $42.82M, signaling the core business is still shrinking.

That tension is what creates opportunity. On one side, PETS is cutting costs, restructuring its operations, and talking up sequential net sales improvement. On the other, customer acquisition and retention in pet meds remain tough, and the revenue line proves it. This is not a clean growth story; it’s a turnaround grind.

Traders are also zoning in on the strategic shift. PetMed Express is leaning into new B2B and white-label channels, including a Master Services Agreement with Rural King. That move tries to put PETS products in front of existing retail traffic instead of fighting for every online click. If those partnerships ramp, you could see stabilizing sales even as the company keeps trimming its cost structure.

On the tape, PETS shows sharp intraday swings: a premarket pop over $2.40, then heavy selling back below $2.00, and multiple tests of the $2.10–$2.20 zone. This is classic momentum-fade price action. For day traders, the key is clear levels: $2.30–$2.35 as resistance, the $1.70–$1.75 area as support, and plenty of room in between for short squeezes and panic dips.

Conclusion

PETS today is not a safe, steady story; it is a turnaround speculation built on execution. PetMed Express has narrowed its loss from -$0.56 to -$0.19 per share and is attacking its cost structure, but the revenue slide to $42.82M shows the business is still under pressure. The cash balance buys time. The low enterprise value and price-to-sales ratio show how little the market currently expects from PETS.

For traders, that disconnect is exactly what makes PetMed Express worth tracking on the screens. If management’s B2B and white-label strategy, including the Rural King agreement, starts to stabilize sales while expenses stay lean, the narrative around PETS can shift fast. If not, the stock can stay stuck in the penalty box or drift lower.

The right way to approach this kind of name is with discipline and a plan. As Tim Sykes likes to remind traders, “Patterns repeat, but only if you respect your rules and cut losses quickly.” As millionaire penny stock trader and teacher Tim Sykes, says, “Embrace the journey, the ups and downs; each mistake is a lesson to improve your strategy.”. PETS is a live example of that mindset. Map your levels, size small, react to price rather than hope, and treat every trade in PetMed Express as a lesson in how turnarounds really play out in the market.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”